183 related articles for article (PubMed ID: 10533856)
1. Drug-resistant Pneumocystis carinii.
Meshnick SR
Lancet; 1999 Oct; 354(9187):1318-9. PubMed ID: 10533856
[No Abstract] [Full Text] [Related]
2. Failure of co-trimoxazole in Pneumocystis carinii infection and mutations in dihydropteroate synthase gene.
Mei Q; Gurunathan S; Masur H; Kovacs JA
Lancet; 1998 May; 351(9116):1631-2. PubMed ID: 9620722
[No Abstract] [Full Text] [Related]
3. Effect of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of P carinii pneumonia in patients with HIV-1: a prospective study.
Navin TR; Beard CB; Huang L; del Rio C; Lee S; Pieniazek NJ; Carter JL; Le T; Hightower A; Rimland D
Lancet; 2001 Aug; 358(9281):545-9. PubMed ID: 11520525
[TBL] [Abstract][Full Text] [Related]
4. Pneumocystis carinii mutations associated with sulfa and sulfone prophylaxis failures in AIDS patients.
Kazanjian P; Locke AB; Hossler PA; Lane BR; Bartlett MS; Smith JW; Cannon M; Meshnick SR
AIDS; 1998 May; 12(8):873-8. PubMed ID: 9631140
[TBL] [Abstract][Full Text] [Related]
5. Pneumocystis carinii dihydropteroate synthase but not dihydrofolate reductase gene mutations correlate with prior trimethoprim-sulfamethoxazole or dapsone use.
Ma L; Borio L; Masur H; Kovacs JA
J Infect Dis; 1999 Dec; 180(6):1969-78. PubMed ID: 10558954
[TBL] [Abstract][Full Text] [Related]
6. Contribution of dihydropteroate synthase gene typing for Pneumocystis carinii f.sp. hominis epidemiology.
Santos LD; Lacube P; Latouche S; Kac G; Mayaud C; Marteau M; Poirot JL; Maury E; Guillot J; Roux P
J Eukaryot Microbiol; 1999; 46(5):133S-134S. PubMed ID: 10519287
[No Abstract] [Full Text] [Related]
7. Atovaquone compared with dapsone to prevent Pneumocystis carinii pneumonia.
Horowitz HW; Wormser GP
N Engl J Med; 1999 May; 340(19):1512-3. PubMed ID: 10328722
[No Abstract] [Full Text] [Related]
8. Pneumocystis carinii dihydropteroate synthase mutations and treatment with sulfa or sulfone regimens: a proposal for standardized definitions for clinical evaluation.
Huang L; Morris AM; Beard CB
J Eukaryot Microbiol; 2001; Suppl():180S-181S. PubMed ID: 11906054
[No Abstract] [Full Text] [Related]
9. Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P. carinii pneumonia.
Helweg-Larsen J; Benfield TL; Eugen-Olsen J; Lundgren JD; Lundgren B
Lancet; 1999 Oct; 354(9187):1347-51. PubMed ID: 10533864
[TBL] [Abstract][Full Text] [Related]
10. Comparison of trimethoprim-sulfamethoxazole, dapsone, and pentamidine in the prophylaxis of Pneumocystis carinii pneumonia.
Warnock AC; Rimland D
Pharmacotherapy; 1996; 16(6):1030-8. PubMed ID: 8947975
[TBL] [Abstract][Full Text] [Related]
11. Alternative dapsone dosage regimen for prophylaxis of Pneumocystis carinii pneumonia.
Gatti G; Fioredda F; Lorusso C; Cruciani M; Bassetti D
Pediatr Infect Dis J; 1996 Feb; 15(2):183-4. PubMed ID: 8822303
[No Abstract] [Full Text] [Related]
12. Reasons for failure of prophylaxis for Pneumocystis carinii pneumonia.
Edge MD; Rimland D
AIDS; 1999 May; 13(8):991-2. PubMed ID: 10371182
[No Abstract] [Full Text] [Related]
13. Does dapsone increase mortality when given for prophylaxis of Pneumocystis carinii pneumonia?
Opravil M; Hirschel B; Lüthy R
AIDS; 1996 Aug; 10(9):1045-6. PubMed ID: 8853742
[No Abstract] [Full Text] [Related]
14. Penetration of dapsone into lung of human immunodeficiency virus-infected children.
Gatti G; Loy A; Lorusso C; Rossi G; Bassetti D
Pediatr Infect Dis J; 1997 May; 16(5):523-4. PubMed ID: 9154550
[No Abstract] [Full Text] [Related]
15. Bilateral upper-lobe cavitary Pneumocystis carinii pneumonia in a patient on dapsone prophylaxis.
Jawahar DA; Dama S; Miarrostami R; Sadagdhar H; Anandarao N
Am J Med Sci; 1999 Feb; 317(2):137-9. PubMed ID: 10037118
[TBL] [Abstract][Full Text] [Related]
16. Adverse reactions associated with dapsone therapy in HIV-positive patients: a case presentation and review.
Stroup JS; Stephens JR; Reust R; Miller JA
AIDS Read; 2006 Jan; 16(1):47-8, 53-5; discussion 54-5. PubMed ID: 16433472
[TBL] [Abstract][Full Text] [Related]
17. Successful desensitization to dapsone for Pneumocystis carinii prophylaxis in an HIV-positive patient.
Cook DE; Kossey JL
Ann Pharmacother; 1998 Dec; 32(12):1302-5. PubMed ID: 9876811
[TBL] [Abstract][Full Text] [Related]
18. Acute generalised exanthematous pustulosis induced by Pneumocystis jirovecii pneumonia prophylaxis with dapsone.
Vas A; Laws P; Marsland A; McQuillan O
Int J STD AIDS; 2013 Sep; 24(9):745-7. PubMed ID: 24026795
[TBL] [Abstract][Full Text] [Related]
19. Increase in prevalence of Pneumocystis carinii mutations in patients with AIDS and P. carinii pneumonia, in the United States and China.
Kazanjian PH; Fisk D; Armstrong W; Shulin Q; Liwei H; Ke Z; Meshnick S
J Infect Dis; 2004 May; 189(9):1684-7. PubMed ID: 15116306
[TBL] [Abstract][Full Text] [Related]
20. How to interpret an overview: a meta-analysis of the relative efficacy and toxicity of Pneumocystis carinii prophylactic regimens.
Easterbrook PJ
Genitourin Med; 1997 Apr; 73(2):139-43. PubMed ID: 9215100
[No Abstract] [Full Text] [Related]
[Next] [New Search]
